-
Je něco špatně v tomto záznamu ?
Olfactory dysfunction in narcolepsy with and without cataplexy
J. Buskova, J. Klaschka, K. Sonka, S. Nevsimalova,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- dospělí MeSH
- fenethylalkohol diagnostické užití MeSH
- hypothalamus patofyziologie MeSH
- intracelulární signální peptidy a proteiny MeSH
- kataplexie diagnóza patofyziologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladý dospělý MeSH
- narkolepsie diagnóza patofyziologie MeSH
- neurony fyziologie MeSH
- neuropeptidy MeSH
- odoranty MeSH
- poruchy čichu diagnóza patofyziologie MeSH
- senioři MeSH
- senzorické prahy fyziologie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
BACKGROUND: Not only patients in whom REM behavior disorder (RBD) is associated with narcolepsy, but also those with narcolepsy alone are reported to have olfactory dysfunction. We investigated if hyposmia is specific to narcolepsy with cataplexy (N-C) or if narcolepsy without cataplexy (NwC) is also associated with olfactory dysfunction. METHODS: We studied olfactory function in two groups of patients: N-C group (n=66, 26 men and 40 women; mean age 41+/-18 years), and NwC group (n=17, 7 men and 10 women; mean age 46+/-20 years). As a control group we used published normative data for particular smell tests. RESULTS: Both patients with N-C and patients suffering from NwC had a significantly higher olfactory threshold (N-C group, p<0.0001; NwC group, p<0.0001) and impaired odor identification (N-C group, p<0.0001; NwC group, p<0.0001). Our results show for the first time that narcolepsy without cataplexy, where the majority of cases have normal CSF hypocretin levels, is associated with olfactory dysfunction. CONCLUSIONS: It appears that also a partial loss of hypothalamic hypocretin neurons without a clear CSF level decrease can affect smell projection.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12025674
- 003
- CZ-PrNML
- 005
- 20121210112225.0
- 007
- ta
- 008
- 120817e20100523ne f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.sleep.2010.01.009 $2 doi
- 035 __
- $a (PubMed)20513636
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Buskova, Jitka $u Department of Neurology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic. vankjit@seznam.cz
- 245 10
- $a Olfactory dysfunction in narcolepsy with and without cataplexy / $c J. Buskova, J. Klaschka, K. Sonka, S. Nevsimalova,
- 520 9_
- $a BACKGROUND: Not only patients in whom REM behavior disorder (RBD) is associated with narcolepsy, but also those with narcolepsy alone are reported to have olfactory dysfunction. We investigated if hyposmia is specific to narcolepsy with cataplexy (N-C) or if narcolepsy without cataplexy (NwC) is also associated with olfactory dysfunction. METHODS: We studied olfactory function in two groups of patients: N-C group (n=66, 26 men and 40 women; mean age 41+/-18 years), and NwC group (n=17, 7 men and 10 women; mean age 46+/-20 years). As a control group we used published normative data for particular smell tests. RESULTS: Both patients with N-C and patients suffering from NwC had a significantly higher olfactory threshold (N-C group, p<0.0001; NwC group, p<0.0001) and impaired odor identification (N-C group, p<0.0001; NwC group, p<0.0001). Our results show for the first time that narcolepsy without cataplexy, where the majority of cases have normal CSF hypocretin levels, is associated with olfactory dysfunction. CONCLUSIONS: It appears that also a partial loss of hypothalamic hypocretin neurons without a clear CSF level decrease can affect smell projection.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a kataplexie $x diagnóza $x patofyziologie $7 D002385
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hypothalamus $x patofyziologie $7 D007031
- 650 _2
- $a intracelulární signální peptidy a proteiny $x mok mozkomíšní $7 D047908
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a narkolepsie $x diagnóza $x patofyziologie $7 D009290
- 650 _2
- $a neurony $x fyziologie $7 D009474
- 650 _2
- $a neuropeptidy $x mok mozkomíšní $7 D009479
- 650 _2
- $a odoranty $7 D009812
- 650 _2
- $a poruchy čichu $x diagnóza $x patofyziologie $7 D000857
- 650 _2
- $a fenethylalkohol $x diagnostické užití $7 D010626
- 650 _2
- $a senzorické prahy $x fyziologie $7 D012684
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Klaschka, Jan
- 700 1_
- $a Sonka, Karel
- 700 1_
- $a Nevsimalova, Sona
- 773 0_
- $w MED00006025 $t Sleep medicine $x 1878-5506 $g Roč. 11, č. 6 (20100523), s. 558-61
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/20513636 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120817 $b ABA008
- 991 __
- $a 20121210112301 $b ABA008
- 999 __
- $a ok $b bmc $g 947716 $s 783020
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2010 $b 11 $c 6 $d 558-61 $e 20100523 $i 1878-5506 $m Sleep medicine $n Sleep Med $x MED00006025
- LZP __
- $a Pubmed-20120817/10/03